MW thank you for the article.Quote:Tamiflu Sales & Forecast:...

MW thank you for the article.

Quote:
Tamiflu Sales & Forecast: 2009: $2.200 billion (note table 1 state $2.5b but the table next to Figure 1 has $2.2b)
The exact distribution of national stockpile between Tamiflu and Relenza may be in the 70:30 ratio as recommended by EMEA.

From Table 3: Relenza sales estimate $1.1b

Roche had achieved their targeted production increase of 400 million dozes last month. Roche had also forecast Tamiflu sales for 2009 to be $2.7b. It indicates Roche forecast the $600m Tamiflu sales came from Relenza due to GSK’s pathethic production efforts.

Thank you Leo for Quoting Peter Cook:
“While the positive effect of this expansion on Biota may be significant and GSK have confirmed it has contracts to supply Relenza to over 60 countries, the announcement is focussed on increased manufacturing capacity for Relenza, not orders or sales.

If you examine the statement it says “GSK have confirmed it….. is focussed on increased manufacturing capacity for Relenza, not orders or sales”
Put simply it said “GSK have confirmed it is not focussed on orders or sales“

Don’t Peter Cook understand GSK has an obligation to BTA shareholders to manufacture and market Relenza to “Best Efforts”? During the Avian Flu pandemic despite Tamiflu close monopoly of the antiviral market, Gillead sued Roche and extracted an increase in the royalty payment rate as well as increased marketing and production.

Here we have the idiot Peter Cook selling out the lawsuit for a huge loss and praising GSK’s 1-shop sales tactic using Relenza to sell vaccines. On top of it, Peter Cook’s statement GSK’s is not focussed on orders or sales is a reflection what an idiot Peter Cook is.